Mirati Therapeutics - 48 Year Dividend Yield History | MRTX

Historical dividend payout and yield for Mirati Therapeutics (MRTX) since 1971. The current TTM dividend payout for Mirati Therapeutics (MRTX) as of February 20, 2019 is $0.00. The current dividend yield for Mirati Therapeutics as of February 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.467B $0.000B
Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Bio-Techne Corp (TECH) United States $7.246B 48.82